1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Computed Tomography (CT) Systems Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Computed Tomography (CT) Systems Market, United States 9
3.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2008-2015 9
3.2 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2015-2022 11
3.3 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2008-2015 13
3.4 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2015-2022 15
3.5 Computed Tomography (CT) Systems Market, United States, Average Price ($), 2008-2022 17
3.6 Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), 2014-2015 19
3.7 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2015 20
4 Overview of Key Companies in United States, Computed Tomography (CT) Systems Market 22
4.1 Siemens Limited 22
4.1.1 Company Overview 22
4.2 GE Healthcare Ltd 22
4.2.1 Company Overview 22
4.3 Toshiba Medical Systems Corporation 22
4.3.1 Company Overview 22
4.4 Philips Healthcare 23
4.4.1 Company Overview 23
5 Computed Tomography (CT) Systems Market Pipeline Products 24
6 Financial Deals Landscape 25
6.1 Acquisition 25
6.1.1 Tahoe Investment to Acquire Remaining Stake in Alliance HealthCare Services 25
6.1.2 BioTelemetry Acquires VirtualScopics for up to USD15.5 Million 26
6.2 Partnerships 27
6.2.1 Imbio and GE Healthcare Enter into Partnership 27
6.3 Venture Financing 28
6.3.1 VIDA Diagnostics Raises USD5.1 Million in Series B Round of Financing 28
6.3.2 Fresh Medical Labs Raises USD0.5 Million in Venture Financing 29
7 Recent Developments 30
7.1 Corporate Communications 30
7.1.1 Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index 30
7.1.2 Dec 12, 2016: VIDA Diagnostics names new COO 30
7.1.3 Nov 22, 2016: USC Roski Eye Institute conducted patient trials for breakthrough refractory glaucoma treatment 31
7.1.4 Nov 22, 2016: Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma Gene Expression Classifier in 2017 32
7.1.5 Oct 24, 2016: Analogic Announces Leadership Transition 33
7.1.6 Sep 27, 2016: Camargo Pharmaceutical Services Adds to Medical Device Expertise 34
7.1.7 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 34
7.1.8 Sep 08, 2016: iCAD Announces Management Transition 34
7.1.9 Sep 06, 2016: GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohaler in COPD at ERS International Congress 35
7.1.10 Sep 01, 2016: NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China 37
7.1.11 Aug 31, 2016: Bruce Elder Named CEO of MedQuest 38
7.1.12 Aug 10, 2016: Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts 39
7.1.13 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions 39
7.1.14 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market 40
7.1.15 May 25, 2016: ProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member 40
7.1.16 May 11, 2016: Regeneron and Sanofi Genzyme to Present Additional Data from Pivotal Phase 2b Dupilumab Study in Adults with Uncontrolled Persistent Asthma at the American Thoracic Society International Conference 41
7.1.17 May 10, 2016: Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA 42
7.1.18 Apr 21, 2016: RefleXion Medical Strengthens Management Team to Bring Biology-Guided Radiotherapy Into the Clinic 44
7.1.19 Feb 25, 2016: Algobate Announces Positive Pre-Phase 3 Meeting With FDA for Naloxone PRT in Opioid Induced Constipation 45
7.1.20 Feb 22, 2016: IMRIS, Deerfield Imaging Board of Directors Appoints Andrew M. Flanagan as Chief Executive Officer 46
7.1.21 Feb 17, 2016: Alliance HealthCare Services Announces Rhonda Longmore-Grund to Assume Chief Financial Officer Role as Part of Planned Transition 46
7.1.22 Feb 08, 2016: Timothy Damadian Named President and CEO of FONAR 47
7.1.23 Jan 26, 2016: Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic’s Board 49
7.1.24 Jan 14, 2016: WellStar Announces New Leadership Roles 49
7.1.25 Jan 11, 2016: Bellicum Pharmaceuticals Announces regulatory milestones and program updates on its CAR T product candidate BPX-401 50
7.2 Financial Announcements 51
7.2.1 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 51
7.2.2 Dec 06, 2016: Analogic Announces Results for the First Quarter ended October 31, 2016 and Declares Quarterly Cash Dividend 52
7.2.3 Nov 09, 2016: FONAR Announces 1st Quarter Financial Results For Fiscal 2017 53
7.2.4 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 55
7.2.5 Nov 03, 2016: Alliance HealthCare Services Reports Results for the Third Quarter Ended September 30, 2016 56
7.2.6 Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results 58
7.2.7 Oct 27, 2016: Stryker reports third quarter 2016 results 60
7.2.8 Oct 27, 2016: Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance 61
7.2.9 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 62
7.2.10 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend 64
7.2.11 Sep 19, 2016: FONAR Announces Fiscal 2016 Year End Earnings 66
7.2.12 Aug 17, 2016: Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results 67
7.2.13 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 69
7.2.14 Aug 04, 2016: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2016 70
7.2.15 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results 72
7.2.16 Jul 25, 2016: Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA 74
7.2.17 Jul 25, 2016: VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate 76
7.2.18 Jul 21, 2016: Stryker reports second quarter 2016 results 76
7.2.19 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 78
7.2.20 Jun 01, 2016: Analogic Announces Results for the Third Quarter Ended April 30, 2016 and Declares Quarterly Cash Dividend 79
7.2.21 May 10, 2016: FONAR Announces 3rd Quarter and Nine Months Financial Results for Fiscal 2016 81
7.2.22 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results 82
7.2.23 May 05, 2016: Alliance HealthCare Services Reports Results for the First Quarter Ended March 31, 2016 84
7.2.24 May 03, 2016: ICAD Reports First Quarter 2016 Financial Results 85
7.2.25 Mar 10, 2016: Alliance HealthCare Services Reports Fourth Quarter & Full Year 2015 Results 87
7.2.26 Mar 02, 2016: Analogic Announces Results for the Second Quarter Ended January 31, 2016 and Declares Quarterly Cash Dividend 90
7.2.27 Mar 01, 2016: iCAD Reports Fourth Quarter and Full Year 2015 Financial Results 91
7.2.28 Feb 09, 2016: FONAR Announces Fiscal 2016 2nd Quarter and Six Months Financial Results 93
7.3 Government and Public Interest 95
7.3.1 Jun 05, 2016: LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer 95
7.3.2 May 23, 2016: Teijin Pharma’s Feburic (Febuxostat) Approved as Indication for Cancer Chemotherapy-Induced Hyperuricemia 97
7.3.3 May 22, 2016: Data from New Analyses of Studies with Veltassa Presented at 53rd European Renal Association Congress 98
7.3.4 Apr 25, 2016: GlycoMimetics Data on GMI-1271 Treatment of Acetaminophen-Triggered Liver Toxicity to Be Presented at "Digestive Disease Week" Conference 100
7.3.5 Apr 13, 2016: Bio Products Laboratory Announces FDA Submission of Biologics License Supplement for Gammaplex 10% 101
7.3.6 Mar 01, 2016: Nordic Nanovector: Late-Breaking Abstract on Betalutin Phase 1/2 Study Accepted for Presentation at American Association for Cancer Research Annual Meeting 2016 102
7.3.7 Jan 28, 2016: European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV 103
7.4 Legal And Regulatory 105
7.4.1 Aug 15, 2016: Med Center Health Facilities Earn ACR Lung Cancer Screening Center Designation 105
7.5 Other Significant Developments 105
7.5.1 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program 105
7.5.2 Jun 21, 2016: iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography 106
7.5.3 Jun 09, 2016: NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies 107
7.5.4 Apr 01, 2016: BTG announces US launch of LC Bead LUMI, ground-breaking radiopaque embolic bead 107
7.5.5 Mar 22, 2016: The University of Tennessee College of Medicine Launches the World’s First Mobile Stroke Unit with Advanced CT Imaging Capabilities Including CT Angiography Imaging for the Brain and Blood Vessels 109
7.6 Product News 110
7.6.1 Dec 19, 2016: Algorithm provides an extra level of assurance during spine surgery 110
7.6.2 Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis 111
7.6.3 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress 112
7.6.4 Jun 08, 2016: NICE draft recommendation on the use of aflibercept (EYLEA) for management of branch retinal vein occlusion goes against Royal College of Ophthalmologists’ guidance 113
7.6.5 Apr 26, 2016: Philips receives FDA 510(k) clearance of CT imaging solutions for lung cancer screening to help hospitals of all sizes drive earlier detection and improve patient care decisions 114
7.7 Strategy And Business Planning 115
7.7.1 Nov 09, 2016: Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia (ferric citrate) 115
7.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 116
7.7.3 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 117
8 Appendix 119
8.1 Research Methodology 120
8.1.1 Coverage 120
8.1.2 Secondary Research 120
8.1.3 Primary Research 121
8.1.4 Market Modeling and Forecasting 122
8.1.5 Company Share Analysis 123
8.1.6 Distribution Share Analysis 124
8.1.7 Benchmarking 124
8.2 GlobalData Consulting 124
8.3 Contact Us 125
8.4 Disclaimer 125

1.1 List of Tables
Table 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 10
Table 2: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 12
Table 3: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015 14
Table 4: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022 16
Table 5: Computed Tomography (CT) Systems Market, United States, Average Price ($), Historic, 2008-2015 17
Table 6: Computed Tomography (CT) Systems Market, United States, Average Price ($), Forecast, 2015-2022 18
Table 7: Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 19
Table 8: Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2015 21
Table 9: Computed Tomography (CT) Systems Market Pipeline Products 24
Table 10: Tahoe Investment to Acquire Remaining Stake in Alliance HealthCare Services 25
Table 11: BioTelemetry Acquires VirtualScopics for up to USD15.5 Million 26
Table 12: Imbio and GE Healthcare Enter into Partnership 27
Table 13: VIDA Diagnostics Raises USD5.1 Million in Series B Round of Financing 28
Table 14: Fresh Medical Labs Raises USD0.5 Million in Venture Financing 29
Table 15: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country 122

1.2 List of Figures
Figure 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 9
Figure 2: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 11
Figure 3: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015 13
Figure 4: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022 15
Figure 5: Computed Tomography (CT) Systems Market, United States, Company Share (%) 2015 20